0.00Open0.00Pre Close0 Volume0 Open Interest12.50Strike Price0.00Turnover6814.64%IV62.13%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.3224Delta0.0725Gamma--Leverage Ratio-23.9207Theta0.0000Rho0.00Eff Leverage0.0003Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$